Skip to content

Trocar Style Needle/Co-Axial Introducer Needle

by Promex, Inc.

510(k) K954265

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK954265 Date29 Sep 1995ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
KNW
Device Class
Class II
Regulation
21 CFR Part 876.1075
Advisory Committee
Gastroenterology, Urology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a trocar-style needle/co-axial introducer needle, classified under product code KNW as an instrument for biopsy procedures. It is designed to facilitate the insertion of biopsy instruments or catheters into tissue, reducing trauma and improving access during minimally invasive procedures in gastroenterology and urology.

The device is supplied sterile and intended for single-use. It is regulated under FDA 510(k) clearance (K954265) and falls under Class II special controls, with a regulatory number of 876.1075. No MRI safety information or reusable specifications are provided in the data. Storage and handling must comply with standard sterile instrument protocols.

Other devices from Promex, Inc.

See all devices from Promex, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of medical procedures is this trocar-style needle designed to assist with, and why is it beneficial in those settings?

    This trocar-style needle/co-axial introducer needle is specifically designed for gastroenterology and urology procedures, particularly to facilitate the insertion of biopsy instruments or catheters. Its trocar-style and co-axial design help minimize tissue trauma and provide improved access during minimally invasive interventions, reducing complications and patient discomfort compared to traditional methods.

  • Is this device reusable, or is it meant for single-use only? How should it be handled to maintain sterility?

    The device is intended for single-use only and is supplied sterile. To preserve sterility, it must be handled according to standard sterile instrument protocols—keeping the packaging intact until use, avoiding contamination, and adhering to manufacturer guidelines for storage and preparation.

  • What sizes or models of this trocar-style needle are available, and how might a clinician choose the right one for a procedure?

    While the provided data does not specify exact sizes or model variations, the device is categorized under product code KNW, which typically includes different gauges or lengths for biopsy introducers. Selection would depend on the procedure requirements, tissue type, and instrument compatibility—clinicians should refer to the manufacturer’s documentation for recommended sizes based on their specific application.

  • How is this device regulated, and what does its FDA clearance mean for its use in clinical settings?

    This device holds an FDA 510(k) clearance (K954265) under Class II special controls, meaning it has been deemed substantially equivalent to a legally marketed predicate device. This clearance confirms it meets regulatory standards for safety and effectiveness in its intended use—facilitating minimally invasive biopsy or catheter insertion in gastroenterology and urology—but does not imply approval for any specific clinical indication beyond its labeled purpose.